Peter Benson

Chairman of the Board of Directors

Finansinspektionen (Sweden) Files from Sweden

Compiled from cited public records — every figure names the disclosure it came from, none copied from any wealth ranking. How we calculate this.

Positions on file
1
positions reconstructed from transactions reported to Finansinspektionen (FI) in Sweden

Not measurable for this profile: Reconstructed positions · 1-day change

Trading activity Feb 10, 2022 – Sep 23, 2025

Peter Benson reported 48 transactions between Feb 10, 2022 and Sep 23, 2025. The buy and sell totals below count only code SACQ.

Open-market buys (SACQ)
1.25M SEK
33 purchases on file priced rows only
Open-market sales
None
0 sales on file
All reported transactions
48
every code, including awards and exercises
Pattern
Net buyer in the final 12 months of the window
last 12 months of the window

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

3 insiders bought Ascelia Pharma AB shares worth 453,548 SEK between Jan 5, 2024 and Jan 8, 2024

Cluster buying

3 different insiders made 5 open-market purchases of this company’s shares within a short window. Each row below is one reported trade.

3 insiders bought Ascelia Pharma AB shares worth 453,548 SEK between Jan 5, 2024 and Jan 8, 2024
Date Insider Transaction Shares Price Value Filing
Jan 5, 2024 Magnus Olafsson Corfitzen SACQ Acquisition 40,000 4.18 SEK 167,165 SEK FI filing ↗
Jan 8, 2024 Peter Benson SACQ Acquisition 5,000 5.84 SEK 29,200 SEK FI filing ↗
Jan 8, 2024 Peter Benson SACQ Acquisition 5,000 5.84 SEK 29,183 SEK FI filing ↗
Jan 8, 2024 Peter Benson SACQ Acquisition 10,000 5.85 SEK 58,500 SEK FI filing ↗
Jan 8, 2024 Julie Brogren SACQ Acquisition 30,000 5.65 SEK 169,500 SEK FI filing ↗

Total of the rows above: 453,548 SEK, in the currency the filings report.

Source: Finansinspektionen (Sweden); every row links to where it was published. Event computed Sep 14, 2026.

5 insiders bought Ascelia Pharma AB shares worth 1,538,794 SEK between Dec 6, 2022 and Dec 16, 2022

Cluster buying

5 different insiders made 10 open-market purchases of this company’s shares within a short window. Each row below is one reported trade.

5 insiders bought Ascelia Pharma AB shares worth 1,538,794 SEK between Dec 6, 2022 and Dec 16, 2022
Date Insider Transaction Shares Price Value Filing
Dec 6, 2022 Peter Benson SACQ Acquisition 1,475 17.36 SEK 25,606 SEK FI filing ↗
Dec 6, 2022 Peter Benson SACQ Acquisition 10,500 17.32 SEK 181,860 SEK FI filing ↗
Dec 6, 2022 Peter Benson SACQ Acquisition 500 17.34 SEK 8,670 SEK FI filing ↗
Dec 6, 2022 Peter Benson SACQ Acquisition 200 17.22 SEK 3,444 SEK FI filing ↗
Dec 6, 2022 Peter Benson SACQ Acquisition 325 17.20 SEK 5,590 SEK FI filing ↗
Dec 6, 2022 Magnus Olafsson Corfitzen SACQ Acquisition 10,000 16.63 SEK 166,314 SEK FI filing ↗
Dec 8, 2022 Rene Spogard SACQ Acquisition 44,500 17.50 SEK 778,750 SEK FI filing ↗
Dec 9, 2022 Julie Brogren SACQ Acquisition 7,000 15.88 SEK 111,160 SEK FI filing ↗
Dec 12, 2022 Peter Benson SACQ Acquisition 5,000 15.48 SEK 77,400 SEK FI filing ↗
Dec 16, 2022 Helena Wennerström SACQ Acquisition 12,000 15.00 SEK 180,000 SEK FI filing ↗

Total of the rows above: 1,538,794 SEK, in the currency the filings report.

Source: Finansinspektionen (Sweden); every row links to where it was published. Event computed Sep 14, 2026.

3 insiders bought Ascelia Pharma AB shares worth 869,454 SEK between May 16, 2022 and Jun 3, 2022

Cluster buying

3 different insiders made 8 open-market purchases of this company’s shares within a short window. Each row below is one reported trade.

3 insiders bought Ascelia Pharma AB shares worth 869,454 SEK between May 16, 2022 and Jun 3, 2022
Date Insider Transaction Shares Price Value Filing
May 16, 2022 Magnus Olafsson Corfitzen SACQ Acquisition 22,500 20.38 SEK 458,654 SEK FI filing ↗
May 24, 2022 Peter Benson SACQ Acquisition 500 20.30 SEK 10,150 SEK FI filing ↗
May 24, 2022 Peter Benson SACQ Acquisition 1,000 20.25 SEK 20,250 SEK FI filing ↗
May 25, 2022 Peter Benson SACQ Acquisition 1,000 20.15 SEK 20,150 SEK FI filing ↗
May 25, 2022 Peter Benson SACQ Acquisition 1,000 20.30 SEK 20,300 SEK FI filing ↗
May 25, 2022 Peter Benson SACQ Acquisition 1,000 20.25 SEK 20,250 SEK FI filing ↗
May 25, 2022 Peter Benson SACQ Acquisition 500 20.20 SEK 10,100 SEK FI filing ↗
Jun 3, 2022 Julie Brogren SACQ Acquisition 15,000 20.64 SEK 309,600 SEK FI filing ↗

Total of the rows above: 869,454 SEK, in the currency the filings report.

Source: Finansinspektionen (Sweden); every row links to where it was published. Event computed Sep 14, 2026.

Reported transactions

Price 0.00 is a real reported figure on allotments, gifts and option exercises — not a missing number. The 25 most recent rows are grouped into 12 lines by date, company and transaction type — open a line to see every lot with its own source link. We hold 48 on file in total.

How to read this list

Every row is one insider transaction as reported to FI, with a link back to the FI register filtered to that issuer and publication date. FI publishes no per-report permalink, so the link is a search, not a document. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. Ascelia Pharma AB SACQ Acquisition × 2 23,000 shares 81.6K SEK
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    15,000 3.56 SEK 53.4K SEK FI filing ↗
    8,000 3.53 SEK 28.2K SEK FI filing ↗
  2. Ascelia Pharma AB SEXD Exercise decrease × 3not a buy/sell decision 92,160 shares 198.1K SEK
    The 3 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    20,472 2.15 SEK 44.0K SEK FI filing ↗
    50,000 2.15 SEK 107.5K SEK FI filing ↗
    21,688 2.15 SEK 46.6K SEK FI filing ↗
  3. Ascelia Pharma AB SEXI Exercise increase × 4not a buy/sell decision 98,312 shares 211.4K SEK
    The 4 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    6,152 2.15 SEK 13.2K SEK FI filing ↗
    20,472 2.15 SEK 44.0K SEK FI filing ↗
    50,000 2.15 SEK 107.5K SEK FI filing ↗
    21,688 2.15 SEK 46.6K SEK FI filing ↗
  4. Ascelia Pharma AB SACQ Acquisition 20,000 shares 54.6K SEK at 2.73 SEK FI filing ↗
  5. Ascelia Pharma AB SSUB Subscriptionnot a buy/sell decision 50,000 shares 253.5K SEK at 5.07 SEK FI filing ↗
  6. Ascelia Pharma AB SSUB Subscription × 3not a buy/sell decision 48,312 shares 244.9K SEK
    The 3 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    6,152 5.07 SEK 31.2K SEK FI filing ↗
    20,472 5.07 SEK 103.8K SEK FI filing ↗
    21,688 5.07 SEK 110.0K SEK FI filing ↗
  7. Ascelia Pharma AB SEXD Exercise decrease × 3not a buy/sell decisionreported at zero 78,507 shares 0 SEK
    The 3 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    9,997 0.00 SEKreported at zero 0 SEK FI filing ↗
    33,267 0.00 SEKreported at zero 0 SEK FI filing ↗
    35,243 0.00 SEKreported at zero 0 SEK FI filing ↗
  8. Ascelia Pharma AB SEXD Exercise decreasenot a buy/sell decision 6,152 shares 13.2K SEK at 2.15 SEK FI filing ↗
  9. Ascelia Pharma AB SACQ Acquisition 8,279 shares 62.1K SEK at 7.50 SEK FI filing ↗
  10. Ascelia Pharma AB SACQ Acquisition 5,255 shares 46.2K SEK at 8.79 SEK FI filing ↗
  11. Ascelia Pharma AB SACQ Acquisition × 3 20,000 shares 116.9K SEK
    The 3 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    10,000 5.85 SEK 58.5K SEK FI filing ↗
    5,000 5.84 SEK 29.2K SEK FI filing ↗
    5,000 5.84 SEK 29.2K SEK FI filing ↗
  12. Ascelia Pharma AB SACQ Acquisition × 2 5,000 shares 69.7K SEK
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    1,958 14.08 SEK 27.6K SEK FI filing ↗
    3,042 13.86 SEK 42.2K SEK FI filing ↗

Reconstructed positions

Reconstructed by adding up every transaction this person reported to FI since 2016. FI publishes transactions, not balances, so this is a computed figure, not a disclosed one — and it omits anything held before the register began.

What is not counted here

Each row comes from a public disclosure named on this page. Private companies, real estate, bonds and crypto are not in those disclosures and are therefore not counted here. Shares held through a holding company are recorded against that company, not against the individual behind it.

Equity positions reported to Finansinspektionen (FI) in Sweden, with the disclosure date shown on each row.
Issuer ISIN Security Shares Price Value Form Reported Filing
Ascelia Pharma AB SE0010573113 Ascelia Pharma AB 219,846 — — FI marknadssok.fi.se ↗

Other shareholders on record at the same companies

People who also appear on the shareholder record of a company where Peter Benson reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

Every figure on this page is quoted from the public record named beside it, with the date it was true. Nothing here is our own calculation.

Think a number here is wrong? Check the named disclosure and its date against the tables above — how to report it.

Profile record last refreshed Sep 14, 2026.